Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Explore the unique financial literacy challenges women face and how to overcome them. Empower your financial journey with vital insights.
28,655 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Retail investors sold NVIDIA, Microsoft, and Oracle to fund SpaceX private rounds, signaling a major shift in how eve...
June payrolls rose just 57,000, signaling softer momentum. Yet three AI-driven stocks offer durable upside as corpora...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...
A major fiduciary manager disclosed a sizable purchase in the Vanguard Long-Term Corporate Bond ETF, signaling a stra...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
Analysts weigh a path to $400 per share by 2028 as Apple rides iPhone demand and Services expansion, even as market h...
Imagine an ETF that allocates nearly one-third of its assets to SpaceX. This deep dive explains how that could happen...
Both XLP (State Street) and IYK (iShares) offer refuge in volatile markets. This guide breaks down costs, risk, and i...